The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma

por Deng, Ganlu, Zeng, Shan, Ma, Junli, Zhang, Yan, Qu, Yanling, Han, Ying, Yin, Ling, Cai, Changjing, Guo, Cao, Shen, Hong
Publicado 2017

BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation

por Deng, Ganlu, Zeng, Shan, Qu, Yanling, Luo, Qingqing, Guo, Cao, Yin, Ling, Han, Ying, Li, Yiyi, Cai, Changjing, Fu, Yaojie, Shen, Hong
Publicado 2018

Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China

por Wang, Zhen, Zhang, Xin, Qu, Yanling, Zhang, Shuyang, Chen, Yundai, Chen, Xiaoping, Qi, Xin, Liu, Peijing, Liu, Shuqin, Jiang, Shan, Man, Ronghai, He, Liping, Wu, Ling, Li, Zhanquan, Shang, Yijun, Qiu, Zhaohui, Liu, Feng, Xu, Chenhong, Lai, Chunlin, Ge, Junbo
Publicado 2023

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities

por Wang, Hao, Liu, Dong, Liang, Hanyang, Ba, Zhengqing, Ma, Yue, Xu, Haobo, Wang, Juan, Wang, Tianjie, Tian, Tao, Yang, Jingang, Gao, Xiaojin, Qiao, Shubin, Qu, Yanling, Yang, Zhuoxuan, Guo, Wei, Zhao, Min, Ao, Huiping, Zheng, Xiaodong, Yuan, Jiansong, Yang, Weixian
Publicado 2022

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

por Qi, Litong, Liu, Dexue, Qu, Yanling, Chen, Beijian, Meng, Haiyan, Zhu, Lei, Li, Lipeng, Wang, Shuqing, Liu, Changyi, Zheng, Guanzhong, Lian, Qiufang, Yin, Guotian, Lv, Lingchun, Lu, Di, Chen, Xiaoshu, Xue, Fengtai, An, Pei, Li, Haoyu, Deng, Huan, Li, Li, Qian, Lei, Huo, Yong
Publicado 2023

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial

por Huo, Yong, Chen, Beijian, Lian, Qiufang, Wang, Shuqing, Liu, Lu, Lu, Di, Qu, Yanling, Zheng, Guanzhong, Li, Lipeng, Ji, Yuan, Yin, Guotian, Huang, Wenjun, Xie, Ying, Yang, Xinchun, Gao, Xiufang, An, Pei, Xue, Fengtai, Li, Haoyu, Deng, Huan, Li, Li, Pei, Lijuan, Qian, Lei
Publicado 2023